NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- The global traumatic brain injuries treatment market is expected to grow steadily from USD 112.6 billion in 2017 to USD 156.8 billion in 2024, at a CAGR of 4.8% from 2018 to 2024. Factors propelling the growth of traumatic brain injuries treatment market include increasing number of road accidents and growing number of vulnerable aging population. Moreover, growing research activities on diagnosis management and huge new pipeline of drugs are further boosting the growth of the global traumatic brain injuries treatment market. On the other hand, the high cost of treatment and monitoring device may hinder the growth of the market.
The report segment the global traumatic brain injuries treatment market by Age (children, teenager, and, elder), by Sex (male, and female), by External Causes (falls, motor vehicle-traffic injury, sports, and other), by Treatment (surgery, and drugs (anti-anxiety agent, anti-depressants, anti-psychotics, analgesic, anti-convulsants, anti-coagulants, and other)), by Route of Drug Administration (Parenteral, and oral), by End-User (hospitals, neurologist, pharmacy, and other), and by Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa).
A severe damage caused to the brain by a jolt or bump can result in traumatic brain injury (TBI). Millions of people suffer from brain injuries every year, and half of them rush to get urgent medical assistance due to critical damages. If not treated on time, such injuries can lead to permanent brain damage or death. Majority of traumatic brain injury are from road accidents, followed by combat zones.
Key Findings of the Global Traumatic Brain Injuries Treatment Market Report
- The traumatic brain injuries treatment market is expected to reach USD 156.8 billion by 2024 at CAGR of 4.8%
- Based on the Age, the elder age segment held the major share of the global traumatic brain injuries treatment market owing to increasing incidence of falls and road accident
- On the basis of Treatment, the drug segment holds major share of the global traumatic brain injuries treatment market and expected to grow at a significant rate during the forecast period owing to growing research activities on diagnosis management and huge new pipeline of drugs
- Geographically, North America holds the major share of the global traumatic brain injuries treatment market owing to growing number of TBI (traumatic brain injury) patients, and increasing research and development activity on diagnosis management
- Key players profiled in the global traumatic brain injuries treatment market are Neuren Pharmaceuticals Ltd, TEVA Pharmaceutical Industries Ltd., Grace Laboratories LLC., NeuroScience Pharmaceuticals, Tenax Therapeutics, IschemixInc, Vasopharm GmbH, AmarantusBioScience Holdings, Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, Banayan Biomarkers Inc., among other
New Devices and Drugs Approval Help to Improve Quality of Life in Traumatic Brain Injuries-
Traumatic brain injuries have become a major problem across the globe. It is also a major problem in an elder population due to their high rate of hospitalization and death because of road accidents and fall. Traumatic brain injuries also impact on quality of life such as decision making, memory, and impairing thinking, among other. Such incidences and facts are drawing major key players and government to invest in new drugs or device for treatment of TBI disease. Recently the U.S. FDA (United States Food and Drug Administration) approves first blood test to diagnose brain injury.
Browse full research report with TOC on " Global Traumatic Brain Injuries Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024" at: https://www.energiasmarketresearch.com/global-traumatic-brain-injuries-treatment-market-outlook/
To purchase report: sales@energiasmarketresearch.com
Global Traumatic Brain Injuries Treatment Market – Regional Insight
Geographically, the global traumatic brain injuries treatment market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa. North America holds the major share of global traumatic brain injuries treatment market owing to growing number of TBI (traumatic brain injury) patients, and increasing research and development activity on diagnosis management. Europe is the second largest market share of the global traumatic brain injuries treatment market. Growing incidence in elderly patients, and increasing road traffic accidents, coupled with the government initiatives to funding for traumatic brain injuries project. In Asia-Pacific the growth of the traumatic brain injuries treatment market is due to growing number of neurologist centers and trauma centers and increasing incidences of road accident.
About Energias Market Research Pvt. Ltd. -
Energias Market Research launched with the objective to provide in-depth market analysis, business research solutions, and consultation that is tailored to our client’s specific needs based on our impeccable research methodology.
With a wide range of expertise from various industrial sectors and more than 50 industries that include energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.
Our comprehensive industry-specific knowledge enables us in creating high quality global research outputs. This wide-range capability differentiates us from our competitors.
Contact:
Mr. Alan Andrews
Business Development Manager
For any queries email us: info@energiasmarketresearch.com
To purchase report: sales@energiasmarketresearch.com
Call us: +1-716-239-4915